GLOBAL HEALTH LIMITED Quarterly Results (MEDANTA) — Q2 FY27
GLOBAL HEALTH LIMITED reported revenue of ₹1,469 cr and net profit of ₹221 cr in Q2 FY27 (quarter ended 30 Sept 2026), +39.3% year on year. Below is the full quarter-wise results table with revenue, operating profit, margins, tax, EPS and annual history — updated when Yahoo Finance publishes updated financial statements; exchange filings can appear earlier.
GLOBAL HEALTH LIMITED (MEDANTA) has reported its Q2 FY27 results for the quarter ended 2026-09-30. The company posted revenue of ₹1,469 cr and a net profit of ₹221 cr, translating into earnings per share of ₹8.21.
Compared with the same quarter a year earlier, revenue grew strongly by +33.6% and net profit grew strongly by +39.3%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹299 cr, an operating margin of 20.4% versus 16.5% a year ago — a gain of 3.9 percentage points.
MEDANTA quarter-wise results table
Revenue
₹1,469 cr
+33.6%YoY
Net profit
₹221 cr
+39.3%YoY
Operating profit
₹299 cr
+65.1%YoY
EPS
₹8.21
+39.4%YoY
Swipe sideways to see all columns →
GLOBAL HEALTH LIMITED (MEDANTA) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth
Quarter
Revenue
Operating profit
Net profit
OPM
Net margin
EPS
Profit YoY
Profit QoQ
Q2 FY272026-09-30
₹1,469 cr
₹299 cr
₹221 cr
20.4%
15.0%
₹8.21
+39.3%
+39.0%
Q1 FY272026-06-30
₹1,304 cr
₹218 cr
₹159 cr
16.7%
12.2%
₹5.91
—
+10.2%
Q4 FY262026-03-31
₹1,159 cr
₹177 cr
₹144 cr
15.3%
12.4%
₹5.36
—
+51.5%
Q3 FY262025-12-31
₹1,121 cr
₹156 cr
₹95.02 cr
13.9%
8.5%
₹3.54
—
-40.0%
Q2 FY262025-09-30
₹1,099 cr
₹181 cr
₹158 cr
16.5%
14.4%
₹5.89
—
—
TTM (last 4 quarters)
₹5,053 cr
₹850 cr
₹618 cr
16.8%
12.2%
₹23.02
—
—
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
MEDANTA quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
GLOBAL HEALTH LIMITED quarterly income statement
Particulars
Q2 FY272026-09-30
Q1 FY272026-06-30
Q4 FY262026-03-31
Q3 FY262025-12-31
Q2 FY262025-09-30
Revenue / Sales
₹1,469 cr
₹1,304 cr
₹1,159 cr
₹1,121 cr
₹1,099 cr
Total expenses
₹1,170 cr
₹1,086 cr
₹982 cr
₹965 cr
₹918 cr
Gross profit
₹1,148 cr
₹1,010 cr
₹913 cr
₹865 cr
₹844 cr
Operating profit (EBIT)
₹299 cr
₹218 cr
₹177 cr
₹156 cr
₹181 cr
Operating margin
20.4%
16.7%
15.3%
13.9%
16.5%
Interest cost
₹28.09 cr
₹26.68 cr
₹26.71 cr
₹21.51 cr
₹17.11 cr
Profit before tax
₹295 cr
₹213 cr
₹187 cr
₹120 cr
₹200 cr
Tax expense
₹75.68 cr
₹56.01 cr
₹45.63 cr
₹24.75 cr
₹41.41 cr
Effective tax rate
25.7%
26.3%
24.4%
20.7%
20.7%
Net profit (PAT)
₹221 cr
₹159 cr
₹144 cr
₹95.02 cr
₹158 cr
Net profit margin
15.0%
12.2%
12.4%
8.5%
14.4%
Basic EPS
₹8.21
₹5.91
₹5.36
₹3.54
₹5.89
Diluted EPS
₹8.20
₹5.90
₹5.35
₹3.54
₹5.89
MEDANTA results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter
Growth
Q2 FY27
Q1 FY27
Q4 FY26
Q3 FY26
Q2 FY26
Revenue YoY
+33.6%
—
—
—
—
Revenue QoQ
+12.7%
+12.5%
+3.4%
+2.0%
—
Operating profit YoY
+65.1%
—
—
—
—
Operating profit QoQ
+37.4%
+22.9%
+13.5%
-13.9%
—
Net profit YoY
+39.3%
—
—
—
—
Net profit QoQ
+39.0%
+10.2%
+51.5%
-40.0%
—
EPS YoY
+39.4%
—
—
—
—
EPS QoQ
+38.9%
+10.3%
+51.4%
-39.9%
—
MEDANTA annual results history
Full-year performance for GLOBAL HEALTH LIMITED, useful for reading each quarter in context.
GLOBAL HEALTH LIMITED annual income statement
Particulars
FY262026-03-31
FY252025-03-31
FY242024-03-31
FY232023-03-31
Revenue / Sales
₹4,318 cr
₹3,637 cr
₹3,241 cr
₹2,683 cr
Total expenses
₹3,592 cr
₹2,900 cr
₹2,583 cr
₹2,184 cr
Gross profit
₹3,322 cr
₹2,757 cr
₹2,482 cr
₹2,058 cr
Operating profit (EBIT)
₹727 cr
₹737 cr
₹658 cr
₹499 cr
Operating margin
16.8%
20.3%
20.3%
18.6%
Interest cost
₹78.04 cr
₹64.02 cr
₹72.54 cr
₹77.46 cr
Profit before tax
₹715 cr
₹647 cr
₹627 cr
₹449 cr
Tax expense
₹161 cr
₹166 cr
₹149 cr
₹123 cr
Effective tax rate
22.5%
25.6%
23.8%
27.4%
Net profit (PAT)
₹556 cr
₹481 cr
₹478 cr
₹326 cr
Net profit margin
12.9%
13.2%
14.8%
12.2%
Basic EPS
₹20.71
₹17.92
₹17.80
₹12.58
Diluted EPS
₹20.66
₹17.92
₹17.80
₹12.57
Revenue trend and demand read-through
Topline for Q2 FY27 came in at ₹1,469 cr against ₹1,099 cr in Q2 FY26, and ₹1,304 cr in the preceding Q1 FY27 quarter.
On a sequential basis revenue grew +12.7%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹1,170 cr, or 79.6% of revenue, with operating profit grew +65.1% year on year.
Margins, tax and profitability
Net profit of ₹221 cr works out to a net margin of 15.0% compared with 14.4% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, GLOBAL HEALTH LIMITED reported profit before tax of ₹295 cr, a tax charge of ₹75.68 cr (effective rate 25.7%), interest cost of ₹28.09 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹159 cr in Q1 FY27 to ₹221 cr in Q2 FY27, a change of +39.0%.
Trailing twelve months and annual context
Across the trailing four quarters GLOBAL HEALTH LIMITED has generated revenue of ₹5,053 cr and net profit of ₹618 cr, a trailing net margin of 12.2%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹4,318 cr with net profit of ₹556 cr and EPS of ₹20.71, versus the prior year where revenue grew +18.7% and profit grew +15.6%.
What to watch in the next MEDANTA quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
No next results date is available in the board-meeting calendar. Statement figures update when Yahoo Finance makes them available; this is not an immediate exchange-filing feed.
Financial figures here are supplied through Yahoo Finance fundamentals and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
MEDANTA results coverage
No results report published for MEDANTA yet — our desk covers each quarter within minutes of the filing.
What were GLOBAL HEALTH LIMITED (MEDANTA) Q2 FY27 results?
In Q2 FY27 (quarter ended 30 Sept 2026), GLOBAL HEALTH LIMITED reported revenue of ₹1,469 cr and net profit of ₹221 cr, a change of +39.3% year on year on +33.6% revenue growth. EPS stood at ₹8.21.
What is MEDANTA profit margin in Q2 FY27?
GLOBAL HEALTH LIMITED posted a net profit margin of 15.0% and an operating margin of 20.4% in Q2 FY27. On a trailing twelve-month basis, revenue is ₹5,053 cr and net profit ₹618 cr.
Did MEDANTA results beat the previous quarter?
GLOBAL HEALTH LIMITED net profit changed +39.0% quarter on quarter, from ₹159 cr in Q1 FY27 to ₹221 cr in Q2 FY27.
When are GLOBAL HEALTH LIMITED (MEDANTA) quarterly results?
GLOBAL HEALTH LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see MEDANTA latest quarterly results?
Results coverage for MEDANTA will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the MEDANTA stock page.
What is GLOBAL HEALTH LIMITED annual revenue and profit?
For FY26, GLOBAL HEALTH LIMITED reported full-year revenue of ₹4,318 cr and net profit of ₹556 cr, with EPS of ₹20.71.
How many quarterly results has MEDANTA declared recently?
Past results dates for MEDANTA will be listed here from the exchange calendar.
Results dates: NSE board-meeting calendar. Financial figures: Yahoo Finance fundamentals, not a direct exchange filing feed. Last successful data fetch 13 Nov 2026. Figures can be delayed; results change only when the provider publishes them. For information only, not investment advice.
